<--- Back to Details
First PageDocument Content
Medicine / Clinical medicine / Health / RTT / Prostate cancer / Histopathology / Prostate-specific antigen / Cancer / Benign prostatic hyperplasia / SWOG / Nicholas J. Vogelzang / Simon J. Hall
Date: 2013-06-05 16:03:14
Medicine
Clinical medicine
Health
RTT
Prostate cancer
Histopathology
Prostate-specific antigen
Cancer
Benign prostatic hyperplasia
SWOG
Nicholas J. Vogelzang
Simon J. Hall

MayCURRICULUM VITAE Catherine (Cathy) M. Tangen Current address:

Add to Reading List

Source URL: www.swogstat.org

Download Document from Source Website

File Size: 207,10 KB

Share Document on Facebook

Similar Documents

Medicine / Clinical medicine / Health / RTT / Prostate cancer / Histopathology / Prostate-specific antigen / Cancer / Benign prostatic hyperplasia / SWOG / Nicholas J. Vogelzang / Simon J. Hall

MayCURRICULUM VITAE Catherine (Cathy) M. Tangen Current address:

DocID: 1qKnG - View Document

Clinical medicine / Cancer / Health / Clinical Lung Cancer / Lung cancer / SWOG / Bevacizumab / Nicholas J. Vogelzang / Draft:Alexandros Makriyannis

CURRICULUM VITAE Mary W. Redman, Ph.D. Current Address:

DocID: 1qCPH - View Document

SWOG / Oncology / Health / Nicholas J. Vogelzang

Joseph Unger, PhD 4664 Sunnyside Ave. N • Seattle, WA • 98103 • (cell) • (office) EDUCATION

DocID: 1qmj9 - View Document

Eli Lilly and Company / Nicholas J. Vogelzang / Karen H. Antman

Publications 2014 GERCOR 1. Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 study. Diouf M, Chibaudel B, Filleron T, Tourn

DocID: 1p6hE - View Document

Oncologists / Souzan El-Eid / Michele Fiore / Nicholas J. Vogelzang

Microsoft Outlook - Memo Style

DocID: 1ooDD - View Document